| Financial Year |
March 31 2023 |
| Monetary Funds |
736,179,871.78 |
| Held-for-trading Financial Assets |
172,363,278.89 |
| Notes Receivable |
27,417,433.56 |
| Accounts Receivable |
744,961,288.59 |
| Advances to Suppliers |
42,463,458.79 |
| Other Receivables |
10,236,943.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,371,240,832.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,978,209.96 |
| Total Current Assets |
3,444,284,659.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
62,440,946.86 |
| Fixed Assetes |
3,480,185,402.56 |
| Under-construction Projects |
164,705,304.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
399,514,670.67 |
| R&D expenses |
555,188.68 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
29,974,543.78 |
| Deferred Income Tax Assets |
19,469,660.38 |
| Other Non-Current Assets |
40,900,601.92 |
| Sub-Total of Non-Current Assets |
4,226,204,015.85 |
| Total Assets |
7,670,488,675.04 |
| Short-Term Loans |
390,337,972.24 |
| Trading Financial liabilities |
-- |
| Notes Payable |
652,137,086.34 |
| Accounts Payable |
870,168,427.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,507,268.78 |
| Taxes Payable |
26,285,615.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
228,090,393.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,210,513.71 |
| Other Current Liabilities |
13,598,164.39 |
| Sub-Total of Current Liabilities |
2,345,638,821.70 |
| Long-term Loans |
368,907,619.31 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,109,633.18 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
718,457,643.79 |
| Total Liabilities |
3,064,096,465.49 |
| Paid-In Capital(Or Share Stock) |
934,916,069.00 |
| Capital Surplus |
1,215,624,594.97 |
| Surplus Reserve |
492,204,268.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
803,312,189.83 |
| Minority Stockholder's Interest |
1,173,005,956.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,433,386,253.50 |
| Owner's Equity（Stockholder's Equity） |
4,606,392,209.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,670,488,675.04 |
